BlackRock, Inc. 13D and 13G filings for IDEAYA Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | IDEAYA Biosciences, Inc. IDYA |
BlackRock Inc. BLK |
7,130,507 8.100% |
-1,245,573 (-14.87%) |
Filing |
| 2025-02-05 1:23 pm Purchase |
2024-12-31 | 13G | IDEAYA Biosciences, Inc. IDYA |
BlackRock Inc. BLK |
8,376,080 9.700% |
2,939,412 (+54.07%) |
Filing |
| 2024-01-25 1:48 pm Purchase |
2023-12-31 | 13G | IDEAYA Biosciences, Inc. IDYA |
BlackRock Inc. BLK |
5,436,668 8.400% |
1,899,938 (+53.72%) |
Filing |
| 2023-01-31 1:58 pm Purchase |
2022-12-31 | 13G | IDEAYA Biosciences, Inc. IDYA |
BlackRock Inc. BLK |
3,536,730 7.400% |
807,011 (+29.56%) |
Filing |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | IDEAYA Biosciences, Inc. IDYA |
BlackRock Inc. BLK |
2,729,719 7.100% |
2,729,719 (New Position) |
Filing |